TR Biofab (Korea) Top Management
246710 Stock | KRW 3,145 100.00 3.08% |
Analysis of TR Biofab's management performance can provide insight into the company performance.
246710 |
Symbol | 246710 |
Name | TR Biofab Co |
Type | Stock |
Country | Republic of Korea |
Exchange | KQ |
Information on TR Biofab Co Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
TR Biofab Management Team Effectiveness
The company has return on total asset (ROA) of (0.098) % which means that it has lost $0.098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (36.3581) %, meaning that it generated substantial loss on money invested by shareholders. TR Biofab's management efficiency ratios could be used to measure how well TR Biofab manages its routine affairs as well as how well it operates its assets and liabilities.TR Biofab Workforce Comparison
TR Biofab Co is currently under evaluation in number of employees category among its peers. The total workforce of Health Care Equipment & Supplies industry is presently estimated at about 851. TR Biofab adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care Equipment & Supplies industry.
The company has Profit Margin (PM) of (0.85) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.86) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.86. TR Biofab Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. TR Biofab Price Series Summation is a cross summation of TR Biofab price series and its benchmark/peer.
About TR Biofab Management Performance
The success or failure of an entity such as TR Biofab often depends on how effective the management is. TR Biofab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 246710 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 246710 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
TR Biofab Co., Ltd. researches and develops medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. The company was founded in 2013 and is based in Siheung, South Korea. TR Biofab is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of TR Biofab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TR Biofab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TR Biofab's management manipulating its earnings.
Complementary Tools for 246710 Stock analysis
When running TR Biofab's price analysis, check to measure TR Biofab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TR Biofab is operating at the current time. Most of TR Biofab's value examination focuses on studying past and present price action to predict the probability of TR Biofab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TR Biofab's price. Additionally, you may evaluate how the addition of TR Biofab to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |